NEUREVO is revolutionizing neurological treatments. NEUREVO is a newly founded company, a spin-off from the very well recognized University of Munich. We are an international team of four people with different backgrounds located in Munich. Our mission is to develop first-in-class neuroprotective treatments that effectively protect against multiple neurological disorders. This includes neurodegenerative diseases like ALS or Parkinson's disease and stroke.